Compare ARVN & SLDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ARVN | SLDP |
|---|---|---|
| Founded | 2015 | 2011 |
| Country | United States | United States |
| Employees | N/A | 230 |
| Industry | Biotechnology: Pharmaceutical Preparations | Electrical Products |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 781.0M | 662.3M |
| IPO Year | 2018 | N/A |
| Metric | ARVN | SLDP |
|---|---|---|
| Price | $10.92 | $3.30 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 19 | 2 |
| Target Price | ★ $15.05 | $7.00 |
| AVG Volume (30 Days) | 781.8K | ★ 3.9M |
| Earning Date | 05-04-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 58.84 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $262,600,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $48.90 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.90 | $1.06 |
| 52 Week High | $14.22 | $8.86 |
| Indicator | ARVN | SLDP |
|---|---|---|
| Relative Strength Index (RSI) | 44.75 | 56.44 |
| Support Level | $9.02 | $2.88 |
| Resistance Level | $12.43 | $3.48 |
| Average True Range (ATR) | 0.63 | 0.18 |
| MACD | 0.07 | 0.07 |
| Stochastic Oscillator | 44.71 | 51.94 |
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
Solid Power Inc develops solid-state battery technology and manufacturing processes. Its sulfide-based solid electrolyte material replaces the liquid or gel electrolyte used in traditional lithium-ion battery cells and enables improvement in energy density, battery life and safety performance. The company produces electrolytes on two pilot manufacturing lines using a batch manufacturing process for customer sampling and internal cell development, and manufactures solid-state cells on pre-pilot and pilot cell manufacturing lines. Its cell manufacturing processes are developed around industry-standard lithium-ion battery manufacturing processes and equipment, and it manufactures all cell designs, including cathodes and anodes, using materials sourced from external suppliers.